A BILL 
To reform prescription drug pricing and reduce out-of-pocket 
costs by ensuring consumers benefit from negotiated rebates. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Prescription Drug Re-
4
bate Reform Act of 2019’’. 
5
SEC. 2. COST-SHARING WITH RESPECT TO PRESCRIPTION 
6
DRUGS. 
7
(a) IN GENERAL.—Subpart II of part A of title 
8
XXVII of the Public Health Service Act (42 U.S.C. 
9
04:18 Jul 27, 2019
H3805
2 
•HR 3805 IH
300gg–11 et seq.) is amended by adding at the end the 
1
following: 
2
‘‘SEC. 2729A. COST-SHARING WITH RESPECT TO PRESCRIP-
3
TION DRUGS. 
4
‘‘(a) IN GENERAL.—A group health plan or health 
5
insurance issuer offering group or individual health insur-
6
ance coverage shall set any coinsurance obligation an en-
7
rollee has with respect to a prescription drug covered by 
8
the plan or coverage based on the net price of the drug, 
9
such that no payment by the enrollee with respect to the 
10
drug is based on a percentage of the list price of a drug. 
11
‘‘(b) APPLICABILITY.—Subsection (a)— 
12
‘‘(1) shall apply with respect to a prescription 
13
drug benefit when the enrollee is required to pay a 
14
deductible with respect to such benefits and— 
15
‘‘(A) has not yet satisfied the deductible 
16
under the plan or coverage; or 
17
‘‘(B) has another coinsurance obligation 
18
with respect to such benefits under the plan or 
19
coverage; and 
20
‘‘(2) shall not apply if, with respect to the dis-
21
pensed quantity of a prescription drug, the net price 
22
and list price are the same, or are different by not 
23
more than 1 cent. 
24
04:18 Jul 27, 2019
H3805
3 
•HR 3805 IH
‘‘(c) COPAYMENTS.—Nothing in this section prevents 
1
a group health plan or health insurance issuer from re-
2
quiring a copayment for any prescription drug if such co-
3
payment is not tied to a percent of the specified cost of 
4
the drug. 
5
‘‘(d) DEFINITIONS.—In this section— 
6
‘‘(1) the term ‘coinsurance’ means, with respect 
7
to prescription drug coverage under a group health 
8
plan or group or individual health insurance cov-
9
erage, a payment obligation of an enrollee in such 
10
health plan or health insurance coverage that is 
11
based on a portion or percentage of the specified 
12
cost of a prescription drug, which may be up to 100 
13
percent of that cost; 
14
‘‘(2) the term ‘deductible’ means the payment 
15
obligation of an enrollee in a group health plan or 
16
group or individual health insurance coverage before 
17
the group health plan or group or individual health 
18
insurance coverage will pay any portion of the cost 
19
of prescription drug coverage; 
20
‘‘(3) the term ‘list price’ has the meaning given 
21
the term ‘wholesale acquisition cost’ in section 
22
1847A(c)(6)(B) of the Social Security Act; 
23
‘‘(4) the term ‘net price’ means, with respect to 
24
prescription drug coverage under a group health 
25
04:18 Jul 27, 2019
H3805
4 
•HR 3805 IH
plan or group or individual health insurance cov-
1
erage, the list price of the drug net all rebates, dis-
2
counts, concessions, and other adjustments applied 
3
to the cost paid by the group health plan or health 
4
insurance issuer, or by any other entity that pro-
5
vides pharmacy benefit management services under 
6
a contract with any such group health plan or health 
7
insurance issuer, regardless of whether such adjust-
8
ments are prospective or retrospective; and 
9
‘‘(5) the term ‘prescription drug’ mean a drug, 
10
as defined in section 201(g) of the Federal Food, 
11
Drug, and Cosmetic Act, that is subject to section 
12
503(b)(1) of such Act.’’. 
13
(b) EFFECTIVE DATE.—Section 2729A of the Public 
14
Health Service Act, as added by subsection (a), shall apply 
15
with respect to plan years beginning on or after January 
16
1, 2021. 
17
Æ 
04:18 Jul 27, 2019
H3805
